Event, n (%) | Eptinezumab 300 mg N = 128 |
---|---|
Any TEAE | 91 (71.1) |
Any study drug-related TEAE | 18 (14.1) |
Any severe TEAE | 13 (10.2) |
Any serious TEAE | 5 (3.9) |
Any TEAE leading to study drug withdrawal | 8 (6.3) |
Any TEAE leading to study drug interruption | 10 (7.8) |
Any TEAE resulting in death | 0 |